Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| global_antibiotic_research_development_partnership [2023/03/09 04:15] liam | global_antibiotic_research_development_partnership [2023/03/12 02:02] (current) liam | ||
|---|---|---|---|
| Line 15: | Line 15: | ||
| ^ Name ^ Position | ^ Name ^ Position | ||
| | [[Marco Cavaleri]] | | [[Marco Cavaleri]] | ||
| + | |||
| + | === Partners === | ||
| + | |||
| + | GARDP' | ||
| + | |||
| + | <WRAP column col4> | ||
| + | * [[All India Institute of Medical Sciences]] (AIIMS) | ||
| + | * [[American Society of Microbiology]] (ASM) | ||
| + | * [[Australian Research Council]] (ARC) | ||
| + | * [[Bill & Melinda Gates Foundation]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[British Society for Antimicrobial Chemotherapy]] (BSAC) | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Clinton Health Access Initiative]] (CHAI) | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Department of Health & Social Care]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Drugs for Neglected Diseases Initiative]] (DNDi) | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Federal Ministry of Education and Research of Germany]] (BMBF) | ||
| + | * [[Federal Ministry of Health of Germany]] (BMG) | ||
| + | * [[Foundation for Innovative New Diagnostics]] (FIND) | ||
| + | * [[Global AMR Innovation Fund]] (GAMRIF) | ||
| + | * [[Government of the Grand Duchy of Luxembourg]] | ||
| + | * [[Helmholtz-Institute for Pharmaceutical Research Saarland]] (HIPS) | ||
| + | * [[Hospital for Tropical Diseases]] | ||
| + | * [[Indian Council of Medical Research]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Institut Pasteur Korea]] | ||
| + | * [[Japanese Ministry of Health, Labour and Welfare]] | ||
| + | * [[Kenyan Medical Research Institute]] (KEMRI) | ||
| + | * [[Kirby Institute]] | ||
| + | * [[Leo Model Foundation]] | ||
| + | * [[Luxembourg Development Corporation]] | ||
| + | * [[Medecins Sans Frontières]] (MSF) | ||
| + | * [[Medical Research Council Clinical Trials Unit at University College London]] | ||
| + | * [[Melbourne Sexual Health Clinic]] | ||
| + | * [[Ministry of Health, Welfare and Sport]] | ||
| + | * [[Ministry of Public Health of Thailand]] | ||
| + | * [[National Institute for Communicable Diseases]] (NICD) | ||
| + | * [[National Institute for Health Research]] (NIHR) | ||
| + | * [[National Institute of Allergy and Infectious Diseases]] (NIAID) | ||
| + | * [[National Institutes of Health]] (NIH) | ||
| + | * [[Örebro University Hospital]] | ||
| + | * [[Penta Foundation]] | ||
| + | * [[Pew Charitable Trusts]] | ||
| + | * [[Principality of Monaco]] | ||
| + | * [[Public Health Service Amsterdam]] | ||
| + | * [[Republic and Canton of Geneva]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[South African Medical Research Council]] (SAMRC) | ||
| + | * [[St. George' | ||
| + | * [[Stellenbosch University]] | ||
| + | * [[Swiss Federal Office of Public Health]] (FOPH) | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Thai Red Cross AIDS Research Centre]] | ||
| + | * [[UCL Great Ormond Street Institute of Child Health]] | ||
| + | * [[UK Aid]] | ||
| + | * [[University of Alabama]] | ||
| + | * [[University of Antwerp]] | ||
| + | * [[University of Florida]] | ||
| + | * [[University of KwaZulu Natal]] | ||
| + | * [[University of Liverpool]] | ||
| + | * [[University of Oxford]] | ||
| + | * [[University of Witwatersrand]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Wellcome Trust]] | ||
| + | * [[Wits Health Consortium]] (WHC) | ||
| + | * [[World Health Organization]] | ||
| + | </ | ||
| === REVIVE === | === REVIVE === | ||
| Line 23: | Line 96: | ||
| <WRAP column col4> | <WRAP column col4> | ||
| + | * [[AMR Accelerator]] | ||
| * [[AMR Action Fund]] | * [[AMR Action Fund]] | ||
| * [[AMR Hub]] | * [[AMR Hub]] | ||
| * [[AMR.Solutions]] | * [[AMR.Solutions]] | ||
| + | * [[Antimicrobial Resistance Center]] | ||
| * [[Australian Antimicrobial Resistance Network]] (AAMRNet) | * [[Australian Antimicrobial Resistance Network]] (AAMRNet) | ||
| * [[Australian Society for Antimicrobials]] (ASA) | * [[Australian Society for Antimicrobials]] (ASA) | ||
| Line 38: | Line 113: | ||
| * [[European Society of Clinical Microbiology and Infectious Diseases]] (ESCMID) | * [[European Society of Clinical Microbiology and Infectious Diseases]] (ESCMID) | ||
| * [[Federation of European Microbiological Societies]] | * [[Federation of European Microbiological Societies]] | ||
| + | * [[Gambia Society of Microbiology]] (GaSoM) | ||
| * [[German Center for Infection Research]] (DZIF) | * [[German Center for Infection Research]] (DZIF) | ||
| + | * [[Hellenic Society for Infectious Diseases]] | ||
| + | * [[Helmholtz Centre for Infection Research]] (HZI) | ||
| + | * [[International Society for Infectious Diseases]] (ISID) | ||
| + | * [[Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy]] (IACMAC) | ||
| + | * [[Irish Society of Clinical Microbiologists]] (ISCM) | ||
| * [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR) | * [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR) | ||
| + | * [[Longitude Prize]] | ||
| + | * [[Malaysian Society of Infectious Diseases & Chemotherapy]] | ||
| + | * [[Medical Research Foundation]] | ||
| + | * [[Microbiology Society]] | ||
| + | * [[National PhD Training Programme in AMR]] | ||
| + | * [[Nigeria Centre for Disease Control]] (NCDC) | ||
| + | * [[Nigerian Society for Microbiology]] (NSM) | ||
| + | * [[Open Source Antibiotics]] (OSA) | ||
| + | * [[ReAct]] | ||
| + | * [[ReAct Africa]] | ||
| * [[REPAIR Impact Fund]] | * [[REPAIR Impact Fund]] | ||
| + | * [[Royal College of Surgeons in Ireland University of Medicine and Health Sciences]] | ||
| + | * [[Scottish Microbiology Association]] | ||
| + | * [[pharmaceutical_companies: | ||
| + | * [[Sociedad Argentina de Infectología]] (SADI) | ||
| + | * [[Sociedade Brasileira de Microbiologia]] (SBM) | ||
| + | * [[Sociedade Portuguesa de Microbiologia]] (SPM) | ||
| + | * [[Society of Infectious Disease Singapore]] (SIDS) | ||
| + | * [[South African Society for Microbiology]] | ||
| + | * [[Students Against Superbugs Africa]] | ||
| + | * [[Swiss Society for Infectious Diseases]] | ||
| + | * [[Swiss Society for Microbiology]] (SSM) | ||
| + | * [[Turkish Microbiology Society]] | ||
| + | * [[Uppsala Antibiotic Center]] (UAC) | ||
| + | * [[Wellcome Trust]] | ||
| + | * [[WHO AMR Secretariat]] | ||
| + | * [[World Society for Pediatric Infectious Diseases]] (WSPID) | ||
| </ | </ | ||